4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in CVD and CKD ... in HF and CKD. ... in HFrEF on GDMT ... outcomes in HFrEF ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive ... #HeartFailure #
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... diagnosis #management #cardiology
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
- May mimic HF ... hypertension, pulmonary ... #Management #Cardiology ... #HFpEF #dCHF #Diastolic ... #Treatment #HeartFailure